How to validate antibody specificity for Y37D8A.2 in C. elegans models?
Perform reciprocal immunoprecipitation (IP) with tagged Y37D8A.2 protein and antibody, followed by mass spectrometry to confirm binding partners .
Use RNAi knockdown of Y37D8A.2 in parallel with antibody staining to verify signal reduction in mutant strains .
Include negative controls with smg-2 mutants (NMD-deficient) to rule out nonspecific binding to stabilized mRNA-protein complexes .
What experimental designs are optimal for studying Y37D8A.2’s role in nonsense-mediated decay (NMD)?
How to resolve contradictory data on Y37D8A.2’s interaction with SMG-2?
What strategies address cross-reactivity with paralogs like Y37D8A.6?
How to determine if Y37D8A.2 regulates NMD through ubiquitination?
What bioinformatics tools identify conserved functional motifs in Y37D8A.2 homologs?
How to distinguish substrate-specific vs. global NMD effects in Y37D8A.2 mutants?
What statistical models account for batch effects in antibody-based quantitation?
Functional redundancy: Y37D8A.2 activity partially overlaps with nck-1 in cell corpse clearance pathways, requiring combinatorial genetic screens to parse roles .
Conservation: The Y37D8A.2 locus shares synteny with mammalian NMD regulators, suggesting conserved mechanisms .
Technical caveats: Antibody specificity must be revalidated in smg-5/smg-6 mutants due to altered mRNA surveillance complexes .